-
1
-
2
-
3
-
4
-
5
Vinculin Tension and YAP Activation are Altered in Dystrophic Muscle Cells
Veröffentlicht in The FASEB journal
VolltextArtikel -
6
-
7
-
8
YAP-dependent proliferation by a small molecule targeting annexin A2
Veröffentlicht in Nature chemical biology
VolltextArtikel -
9
Abstract CT006: First-in-class, first-in-human phase 1 trial of VT3989, an inhibitor of yes-associated protein (YAP)/transcriptional enhancer activator domain (TEAD), in patients (pts) with advanced solid tumors enriched for malignant mesothelioma and other tumors with neurofibromatosis 2 (NF2) mutations
Veröffentlicht in Cancer research (Chicago, Ill.)
VolltextArtikel -
10
Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP
Veröffentlicht in Science signaling
VolltextArtikel -
11
Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression
Veröffentlicht in EMBO reports
VolltextArtikel -
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20